(Q40470703)

20 September 2017

1 reference

title

Increasing tumour immunogenicity by genetic modification (English)

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

20 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654453

20 July 2024

author name string

T. Blankenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654453

20 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7654453

20 July 2024

publication date

1 January 1994

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0959804994904804?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

https://api.elsevier.com/content/article/PII:0959804994904804?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

European Journal of Cancer

20 July 2024

published in

1 reference

20 September 2017

volume

30A

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

1182-1187

1 reference

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

20 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1084/JEM.178.2.489

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Toward a genetic analysis of tumor rejection antigens.

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Analysis of antigens recognized on human melanoma cells by A2‐restricted cytolytic t lymphocytes (CTL)

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Cytokines and cancer: experimental systems

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

New strategies for enhancing the immunogenicity of tumors

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

20 July 2024

Tumor antigens

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Monoclonal antibodies in cancer therapy

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Tumor eradication by adoptive transfer of cytotoxic T lymphocytes

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Potential immunogenicity of oncogene and tumor suppressor gene products

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

20 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Murine interleukin-4 displays potent anti-tumor activity in vivo

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicity

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4.

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma

20 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction

20 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

20 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity

20 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth

20 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

DNA rearrangement and constitutive expression of the interleukin 6 gene in a mouse plasmacytoma

20 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

20 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

20 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells

20 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

20 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

20 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity

20 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo

20 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Tumors secreting human TNF/cachectin induce cachexia in mice

20 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity

20 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

20 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

20 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

20 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

20 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression

20 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity

20 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Suppression of tumor formation in vivo by expression of the JE gene in malignant cells

20 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

20 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant

20 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

20 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90480-4

20 July 2024

Identifiers

1 reference

20 September 2017

1 reference